Monozygotic twins discordant for narcolepsy type 1 and multiple sclerosis

Neurology: Neuroimmunology and NeuroInflammation

Volumn 3, Issue 4, 2016, Pages

  Jennum, Poul J ^a   Kornum, Birgitte R ^a   Issa, Nadia M ^a   Gammeltoft, Steen ^a   Tommerup, Niels ^c   Morling, Niels ^c   Tümer, Zeynep ^a   Knudsen, Stine ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c University of Copenhagen   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85032643180     PISSN: None     EISSN: 23327812     Source Type: Journal    
DOI: 10.1212/NXI.0000000000000249     Document Type: Article

References (7)

1. Faraco J, Lin L, Kornum BR, et al. ImmunoChip study implicates antigen presentation to T cells in narcolepsy. PLoS Genet 2013;9:e1003270.
2. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011;69:292–302.
3. Martinez-Orozco FJ, Vicario JL, Villalibre-Valderrey I, De Andrés C, Fernandez-Arquero M, Peraita-Adrados R. Narcolepsy with cataplexy and comorbid immunopathological diseases. J Sleep Res 2014;23:414–419.
4. Vrethem M, Malmgren K, Lindh J. A patient with both narcolepsy and multiple sclerosis in association with Pandemrix vaccination. J Neurol Sci 2012;321:89–91.
5. Knudsen S, Jennum PJ, Korsholm K, Sheikh SP, Gammeltoft S, Frederiksen JL. Normal levels of cerebrospinal fluid hypocretin-1 and daytime sleepiness during attacks of relapsing-remitting multiple sclerosis and monosymptomatic optic neuritis. Mult Scler 2008;14:734–738.
6. Kanbayashi T, Shimohata T, Nakashima I, et al. Symptomatic narcolepsy in patients with neuromyelitis optica and multiple sclerosis: new neurochemical and immunological implications. Arch Neurol 2009;66:1563–1566.
7. Olberg HK, Cox RJ, Nostbakken JK, Aarseth JH, Vedeler CA, Myhr KM. Immunotherapies influence the influenza vaccination response in multiple sclerosis patients: an explorative study. Mult Scler 2014;20:1074–1080.